AbbVie also faced losses in sales for its blockbuster immunology drug Humira (adalimumab), when its US patent expired in January 2023 opening up the market to Humira biosimilars and other competitors.

The Socceroos travel to Bahrain in a crucial World Cup qualifier. Their draw in their previous match over Saudi Arabia means they still sit in second - one of the automatic qualifying places - but ...

Whether you’re a resident or a very lucky visitor who happens to be in the Kingdom when the Bahrain International Airshow is taking off, here’s your first-class ticket to all the ins and outs of this ...

The China Men's National Football Team will take on a crucial away match against Bahrain in the third round of the Asian World Cup qualifiers on November 14. Despite significant pressure from ...

Some parts of Medicare, including Part B and Part D, may cover the approved drug Humira (adalimumab). However, some Medicare Advantage plans may also offer coverage. Humira contains the active ...

First to earn FDA approval in the space was AbbVie’s Humira in 2015, followed by Novartis’ Cosentyx in late 2023. Meanwhile, UCB has also delivered promising data for Bimzelx in HS ...